Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice

Journal of Crohn's and Colitis

Volumn 8, Issue 12, 2014, Pages 1710-1722

  Zuo, Lugen ^a   Li, Yi ^a   Wang, Honggang ^a   Wu, Rong ^a   Zhu, Weiming ^a   Zhang, Wei ^a   Cao, Lei ^a   Gu, Lili ^a   Gong, Jianfeng ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Animal model; Cigarette smoke; Crohn's disease; Intestinal barrier; Ulcerative colitis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; ANIMAL MODEL; ATROPHY; BACTERIAL TRANSLOCATION; BAGG ALBINO MOUSE; INTESTINE; INTESTINE MUCOSA; LARGE INTESTINE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; SMALL INTESTINE; SMOKING; TIGHT JUNCTION;

ANIMALS; ATROPHY; BACTERIAL TRANSLOCATION; INTESTINAL MUCOSA; INTESTINE, LARGE; INTESTINE, SMALL; INTESTINES; MICE, INBRED BALB C; MODELS, ANIMAL; NF-KAPPA B; PERMEABILITY; SMOKING; TIGHT JUNCTIONS;

EID: 84918530112     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.08.008     Document Type: Article

References (53)

1. Ananthakrishnan A.N. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep 2013, 15(1):302.
2. Lakatos P.L., Szamosi T., Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly. World J Gastroenterol 2007, 13(46):6134-6139.
3. McGuckin M.A., Eri R., Simms L.A., Florin T.H., Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009, 15(1):100-113.
4. Porras M., Martin M.T., Yang P.C., Jury J., Perdue M.H., Vergara P. Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation. Inflamm Bowel Dis 2006, 12(9):843-852.
5. Verschuere S., De Smet R., Allais L., Cuvelier C.A. The effect of smoking on intestinal inflammation: what can be learned from animal models. J Crohns Colitis 2012, 6(1):1-12.
6. Parkes G.C., Whelan K., Lindsay J.O. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 2014, 8(8):717-725.
7. Prytz H., Benoni C., Tagesson C. Does smoking tighten the gut. Scand J Gastroenterol 1989, 24(9):1084-1088.
8. Suenaert P., Bulteel V., Den H.E., Hiele M., Peeters M., Monsuur F., et al. The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther 2000, 14(6):819-822.
9. Benoni C., Prytz H. Effects of smoking on the urine excretion of oral 51Cr EDTA in ulcerative colitis. Gut 1998, 42(5):656-658.
10. Braber S., Henricks P.A., Nijkamp F.P., Kraneveld A.D., Folkerts G. Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir Res 2010, 11:99.
11. D'hulst A.I., Vermaelen K.Y., Brusselle G.G., Joos G.F., Pauwels R.A. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005, 26(2):204-213.
12. Verschuere S., Bracke K.R., Demoor T., Plantinga M., Verbrugghe P., Ferdinande L., et al. Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. Lab Invest 2011, 91(7):1056-1067.
13. Macdonald G., Kondor N., Yousefi V., Green A., Wong F., Aquino-Parsons C. Reduction of carboxyhaemoglobin levels in the venous blood of cigarette smokers following the administration of carbogen. Radiother Oncol 2004, 73(3):367-371.
14. Muhammad-Kah R.S., Hayden A.D., Liang Q., Frost-Pineda K., Sarkar M. The relationship between nicotine dependence scores and biomarkers of exposure in adult cigarette smokers. Regul Toxicol Pharmacol 2011, 60(1):79-83.
15. Gareau M.G., Jury J., Perdue M.H. Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability. Am J Physiol Gastrointest Liver Physiol 2007, 293(1):G198-G203.
16. Wang H., Zhang W., Zuo L., Zhu W., Wang B., Li Q., et al. Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. Br J Nutr 2013, 109(11):1990-1998.
17. Kosiewicz M.M., Nast C.C., Krishnan A., Rivera-Nieves J., Moskaluk C.A., Matsumoto S., et al. Th-1type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest 2001, 107(6):695-702.
18. Wu L.L., Chiu H.D., Peng W.H., Lin B.R., Lu K.S., Lu Y.Z., et al. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta. Crit Care Med 2011, 39(9):2087-2098.
19. Ke S.Z., Ni X.Y., Zhang Y.H., Wang Y.N., Wu B., Gao F.G. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-kappaB pathway in lung cancer cells. Int J Oncol 2013, 42(4):1289-1296.
20. Di P.N.C., Tuve S., Ni S., Hellstrom K.E., Hellstrom I., Lieber A. Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses. Cancer Res 2006, 66(2):960-969.
21. Cheng Y.T., Wu S.L., Ho C.Y., Huang S.M., Cheng C.L., Yen GC. Beneficial Effects of Camellia Oil (Camellia oleifera Abel.) on Ketoprofen-Induced Gastrointestinal Mucosal Damage through Upregulation of HO-1 and VEGF. J Agric Food Chem 2014, Jan 9 [Epub ahead of print].
22. Dong W., Zhang Z., Liu Z., Liu H., Wang X., Bi S., et al. Protective effects of osthole, a natural derivative of coumarin, against intestinal ischemia-reperfusion injury in mice. Int J Mol Med 2013, 31(6):1367-1374.
23. Stenman L.K., Holma R., Eggert A., Korpela R. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol 2013, 304(3):G227-G234.
24. He Z.W., Qin Y.H., Wang Z.W., Chen Y., Shen Q., Dai S.M. HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-kappaB signaling pathways. Mediators Inflamm 2013, 2013:596716.
25. Schulzke J.D., BCheng YT, Wu SL, Ho CY, Huang SM, Cheng CL,Yen GC.Beneficial Effects of Camellia Oil (Camellia oleifera Abel.) on Ketoprofen-Induced Gastrointestinal Mucosal Damage through Upregulation of HO-1 and VEGF.J Agric Food Chem 2014 Jan 9 [Epub ahead of print].ojarski C., Zeissig S., Heller F., Gitter A.H., Fromm M. Disrupted barrier function through epithelial cell apoptosis. Ann N Y Acad Sci 2006, 1072:288-299.
26. Watson A.J., Hughes K.R. TNF-alpha-induced intestinal epithelial cell shedding: implications for intestinal barrier function. Ann N Y Acad Sci 2012, 1258:1-8.
27. Ma T.Y., Iwamoto G.K., Hoa N.T., Akotia V., Pedram A., Boivin M.A., et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004, 286(3):G367-G376.
28. Graham W.V., Wang F., Clayburgh D.R., Cheng J.X., Yoon B., Wang Y., et al. Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter. J Biol Chem 2006, 281(36):26205-26215.
29. Amasheh M., Fromm A., Krug S.M., Amasheh S., Andres S., Zeitz M., et al. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J Cell Sci 2010, 123(Pt23):4145-4155.
30. Chen H.Q., Yang J., Zhang M., Zhou Y.K., Shen T.Y., Chu Z.X., et al. Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice. Am J Physiol Gastrointest Liver Physiol 2010, 299(6):G1287-G1297.
31. Takahashi A., Kondoh M., Suzuki H., Watari A., Yagi K. Pathological changes in tight junctions and potential applications into therapies. Drug Discov Today 2012, 17(13-14):727-732.
32. Barksby H.E., Lea S.R., Preshaw P.M., Taylor J.J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 2007, 149(2):217-225.
33. Al-Sadi R.M., Ma T.Y. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007, 178(7):4641-4649.
34. Al-Sadi R., Ye D., Dokladny K., Ma T.Y. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 2008, 180(8):5653-5661.
35. Al-Sadi R., Ye D., Said H.M., Ma T.Y. IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway. Am J Pathol 2010, 177(5):2310-2322.
36. Sappington P.L., Yang R., Yang H., Tracey K.J., Delude R.L., Fink M.P. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002, 123(3):790-802.
37. Ye D., Ma I., Ma T.Y. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006, 290(3):G496-G504.
38. Eliakim R., Karmeli F., Cohen P., Heyman S.N., Rachmilewitz D. Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats. Int J Colorectal Dis 2001, 16(1):14-21.
39. Wang H., Zhao J.X., Hu N., Ren J., Du M., Zhu M.J. Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins. World J Gastroenterol 2012, 18(18):2180-2187.
40. van der Heide F., Dijkstra A., Weersma R.K., Albersnagel F.A., van der Logt E.M., Faber K.N., et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009, 15(8):1199-1207.
41. Kennelly R.P., Subramaniam T., Egan L.J., Joyce M.R. Smoking and Crohn's disease: active modification of an independent risk factor (education alone is not enough). J Crohns Colitis 2013, 7(8):631-635.
42. Bergeron V., Grondin V., Rajca S., Maubert M.A., Pigneur B., Thomas G., et al. Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease. Inflamm Bowel Dis 2012, 18(6):1101-1111.
43. Birrenbach T., Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004, 10(6):848-859.
44. Randell R.L., Long M.D., Cook S.F., et al. Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners). Inflamm Bowel Dis 2014, 20(3):541-544.
45. Bressenot A., Geboes K., Vignaud J.M., Gueant J.L., Peyrin-Biroulet L. Microscopic features for initial diagnosis and disease activity evaluation in inflammatory bowel disease. Inflamm Bowel Dis 2013, 19(8):1745-1752.
46. Feiner J.R., Rollins M.D., Sall J.W., Eilers H., Au P., Bickler P.E. Accuracy of carboxyhemoglobin detection by pulse CO-oximetry during hypoxemia. Anesth Analg 2013, 117(4):847-858.
47. van Wijck K., Lenaerts K., van Loon L.J., Peters W.H., Buurman W.A., Dejong C.H. Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One 2011, 6(7):e22366.
48. Van Wijck K., Lenaerts K., Van Bijnen A.A., et al. Aggravation of exercise-induced intestinal injury by Ibuprofen in athletes. Med Sci Sports Exerc 2012, 44(12):2257-2262.
49. Cameron H.L., Perdue M.H. Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther 2005, 314(1):214-220.
50. Teitelbaum A.A., Gareau M.G., Jury J., Yang P.C., Perdue M.H. Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress. Am J Physiol Gastrointest Liver Physiol 2008, 295(3):G452-G459.
51. Rom O., Avezov K., Aizenbud D., Reznick A.Z. Cigarette smoking and inflammation revisited. Respir Physiol Neurobiol 2013, 187(1):5-10.
52. Mehta H., Nazzal K., Sadikot R.T. Cigarette smoking and innate immunity. Inflamm Res 2008, 57(11):497-503.
53. Leach P.T., Cordero K.A., Gould T.J. The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on performance of a cued appetitive response. Behav Neurosci 2013, 127(2):303-310.